CAPS Rating

CheapHessian (< 20)

Results 1 - 20 of 45 : 1 2 3 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
17/03/2014 TGD.US 1 out of 5 Outperform 5Y $1.70 $1.31 (-1.50%) -22.94% +4.57% -27.51
17/03/2014 FNV.US 3 out of 5 Outperform 5Y $52.01 $53.89 (-2.66%) +3.61% +4.57% -0.96
17/03/2014 LODE.US 1 out of 5 Outperform 5Y $1.94 $1.32 (+1.54%) -31.96% +4.57% -36.53
17/03/2014 GDXJ.US 3 out of 5 Outperform 5Y $44.33 $32.83 (-0.03%) -25.94% +4.57% -30.51
17/03/2014 AEM.US 4 out of 5 Outperform 5Y $34.20 $30.31 (-0.07%) -11.39% +4.57% -15.95
17/03/2014 ANV.US 2 out of 5 Outperform 5Y $6.37 $2.46 (-1.60%) -61.38% +4.57% -65.95
17/03/2014 GG.US 3 out of 5 Outperform 5Y $28.12 $23.22 (-0.34%) -17.42% +4.57% -21.99
29/02/2012 16/03/2014 AMZN.US 3 out of 5 Underperform 3Y $179.70 $315.33 (+2.98%) +75.48% +41.31% -34.17
26/02/2013 EXK.US 3 out of 5 Outperform 5Y $6.21 $4.15 (-1.66%) -33.17% +29.62% -62.79
11/02/2013 FSM.US 2 out of 5 Outperform 5Y $4.47 $4.65 (-1.69%) +4.03% +27.90% -23.87
11/02/2013 PAAS.US 3 out of 5 Outperform 5Y $16.32 $10.80 (+0.09%) -33.80% +27.90% -61.70
05/02/2013 RIC.US 2 out of 5 Outperform 5Y $3.20 $2.57 (-1.15%) -19.69% +29.08% -48.77
05/02/2013 AXU.US 4 out of 5 Outperform 5Y $4.58 $0.55 (+1.20%) -87.99% +29.08% -117.07
04/02/2013 SSRI.US 4 out of 5 Outperform 5Y $12.09 $5.74 (+0.35%) -52.52% +29.10% -81.63
04/02/2013 GORO.US 1 out of 5 Outperform 5Y $12.60 $4.87 (-4.88%) -61.36% +29.10% -90.47
24/01/2013 SGSVF.US 2 out of 5 Outperform 5Y $2.51 $0.48 (+8.69%) -81.07% +30.12% -111.19
23/01/2013 NRT.US 4 out of 5 Outperform 1Y $21.76 $19.52 (+0.77%) -10.29% +30.13% -40.42
23/01/2013 POT.US 4 out of 5 Outperform 5Y $38.90 $32.89 (+1.17%) -15.44% +30.13% -45.58
23/01/2013 CPE.US 2 out of 5 Outperform 5Y $5.22 $6.29 (+5.71%) +20.50% +30.13% -9.64
14/01/2013 IAG.US 3 out of 5 Outperform 5Y $10.58 $2.43 (-0.41%) -77.04% +32.12% -109.15
Results 1 - 20 of 45 : : 1 2 3 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.